Tomas Hode

NeoPhotonics (United States) — United States

Immunology and Microbiology · Life Sciences

16h-index890citations65works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(23), Photodynamic Therapy Research Studies(23), Nanoplatforms for cancer theranostics(13), Planetary Science and Exploration(9), Cancer Immunotherapy and Biomarkers(7)

Publications65 total

Enhancing the Immunotherapeutic Effect by IP-001 and Irreversible Electroporation in Mouse Oligometastatic Models of Pancreatic Adenocarcinoma
Annals of Surgical Oncology·2024· 1 cited
Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model
International Journal of Hyperthermia·2024· 1 citedOpen Access
<i>N</i>‐Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL‐1β Productions for Antitumor Immunity.
Advanced Functional Materials·2024· 5 citedOpen Access
N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection
Acta Biomaterialia·2023· 4 cited
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
PLoS ONE·2023· 3 citedOpen Access
A novel biopolymer for mucosal adjuvant against respiratory pathogens
2022· 2 citedOpen Access
A novel biopolymer synergizes type I IFN and IL-1β production through STING
2022· 2 citedOpen Access
Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing
Clinical and Translational Medicine·2022· 24 citedOpen Access
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
2021Open Access
Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy
Cells·2021· 30 citedOpen Access
N-dihydrogalactochitosan-supported tumor control by photothermal therapy and photothermal therapy-generated vaccine
Journal of Photochemistry and Photobiology B Biology·2020· 20 cited
N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines
International Immunopharmacology·2019· 35 cited
Laser immunotherapy for advanced solid tumors
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2017
Chapter 4 Is Coherence Important in Photobiomodulation?
Pan Stanford Publishing Pte. Ltd. eBooks·2016
Development of InCVAX as a novel in situ autologous vaccine for metastatic cancers (Conference Presentation)
2016
Advances in strategies and methodologies in cancer immunotherapy.
PubMed·2015· 11 cited
The immunological response created by interstitial and non-invasive laser immunotherapy
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2015
InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity
Cancer Letters·2015· 79 cited
InCVAX as a Novel In Situ Autologous Cancer Vaccine
2015
Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase II clinical trial
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2014· 1 cited
page 1 of 4Next →

Frequent Co-authors

Wei R. Chen(24), Robert E. Nordquist(16), Samuel S.K. Lam(12), Xiaosong Li(10), Sandra Siljeström(9), Peter Sjövall(9), Volker Thiel(6), Jukka Lausmaa(6), Ashley R. Hoover(6), Gabriela L. Ferrel(5), Feifan Zhou(5), Joseph Raker(5), Curt Broman(5), Lu Alleruzzo(5), Maria Cristina Guerra(4), John Lunn(4), Luciano Alleruzzo(4), Coline Furrer(4), Chun Fung Wong(4), Trisha I. Valerio(4)